| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/02/2003 | EP1322599A2 Hiv integrase inhibitors |
| 07/02/2003 | EP1322383A2 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 07/02/2003 | EP1322350A1 E-ptfe foil impregnated with an encapsulated bioactive substance |
| 07/02/2003 | EP1322338A2 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 07/02/2003 | EP1322334A2 Methods of inducing cancer cell death and tumor regression |
| 07/02/2003 | EP1322333A2 Composition for combined use of aromatase inhibitors |
| 07/02/2003 | EP1322331A2 Fatty acid synthase inhibitors |
| 07/02/2003 | EP1322325A1 Inhibiting hepatitis c virus processing and replication |
| 07/02/2003 | EP1322319A1 Use of il-8 protein modulators in the treatment of viral infections |
| 07/02/2003 | EP1322317A1 Compositions and methods for prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with compositions comprising unfractionated cellular proteins |
| 07/02/2003 | EP1322314A2 Treatment of diabetes mellitus by inhibition of mitochondrial calcium/sodium antiporter |
| 07/02/2003 | EP1322310A1 Alpha v integrin receptor antagonists |
| 07/02/2003 | EP1322307A1 Methods for treating cell proliferative disorders and viral infections |
| 07/02/2003 | EP1322302A2 Taxoid conjugates as antimitotic and antitumor agents |
| 07/02/2003 | EP1322301A1 Combination particles for the treatment of asthma |
| 07/02/2003 | EP1322300A1 Inhalation particles incorporating a combination of two or more active ingredients |
| 07/02/2003 | EP1322156A1 Disinfectant |
| 07/02/2003 | EP1227825A4 Isolation and expansion of human marrow stromal cells |
| 07/02/2003 | EP1224180B1 Substituted azoles |
| 07/02/2003 | EP1171444B1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
| 07/02/2003 | EP1150666A4 Stimulating neutrophil function to treat inflammatory bowel disease |
| 07/02/2003 | EP1143994B1 Use of apoptosis inducing agents in the preparation of a medicament for the treatment of (auto)immune diseases |
| 07/02/2003 | EP1059921B1 Use of macrolide compounds for the treatment of acute lung injury |
| 07/02/2003 | EP1045849B1 Purine derivatives having phosphodiesterase iv inhibition activity |
| 07/02/2003 | EP1041966B1 Pharmaceutical compositions comprising zafirlukast |
| 07/02/2003 | EP1028954B1 Substituted imidazoles useful in the treatment of inflammatory diseases |
| 07/02/2003 | EP0991627B1 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 07/02/2003 | EP0975327B1 Use of 5ht3 antagonists for promoting intestinal lavage |
| 07/02/2003 | EP0970067B1 (methylsulfonyl)phenyl-2-(5h)-furanones with oxygen link as cox-2 inhibitors |
| 07/02/2003 | EP0944582B1 Ketobenzamides as calpain inhibitors |
| 07/02/2003 | EP0900211B1 Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors |
| 07/02/2003 | EP0826043B1 Methods for modulating t cell survival by modulating bcl-xl protein level |
| 07/02/2003 | EP0782986B1 Novel heterocyclic derivatives, process for producing the same, and medicinal use thereof |
| 07/02/2003 | EP0740658B1 N-substituted azabicycloheptane derivatives used, for example, as neuroleptics |
| 07/02/2003 | EP0732875B1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
| 07/02/2003 | CN1427889A Hybrid cells obtainable from antigen presenting cells |
| 07/02/2003 | CN1427887A Pluripotent cells comprising allogenic nucleus and mitochondria |
| 07/02/2003 | CN1427845A Cyclipostins, method for their production and use of same |
| 07/02/2003 | CN1427844A Bis-(N,N'-bis-(2-haloethyl) amino) phosphoramidates as antitumor agents |
| 07/02/2003 | CN1427840A Azabicyclic carbamates and their use as alpha-7 nicotinic acetyl choline receptor agonists |
| 07/02/2003 | CN1427838A Hydantoin-containing glucokinase activators |
| 07/02/2003 | CN1427837A Ortho-substituted anthranilic acid amides and their use as medicaments |
| 07/02/2003 | CN1427835A Stepwise Alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans |
| 07/02/2003 | CN1427830A Para-substituted phenylamide glucokinase activators |
| 07/02/2003 | CN1427829A Substituted phenylacetamides and their use as glucokinase activators |
| 07/02/2003 | CN1427826A Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl IV, processes for their preparation, and their use |
| 07/02/2003 | CN1427825A Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
| 07/02/2003 | CN1427818A Factor VIIA inhibitor (thio) urea derivatives, their preparation and their use |
| 07/02/2003 | CN1427726A Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy |
| 07/02/2003 | CN1427725A Casein derived peptides and uses thereof in therapy |
| 07/02/2003 | CN1427722A Method for treatment or prevention of flavivirus infections using nucleoside analogues |
| 07/02/2003 | CN1427718A Pharmaceutical compounds for treating COPD |
| 07/02/2003 | CN1427011A Hemopoiesis factor and its application |
| 07/02/2003 | CN1426813A Recombination human epidermis growth factor spraying agent and its preparation method |
| 07/02/2003 | CN1426812A Relaxation of Climacteric syndrome by using antisenility action of glossy ganoderma |
| 07/02/2003 | CN1426799A 按摩液 Massage fluid |
| 07/02/2003 | CN1426788A Chewing gum for preventing sleepy |
| 07/02/2003 | CN1426787A Health care mixture for antifatigne and enhancing immunity |
| 07/02/2003 | CN1113059C Pipeazino derivatives as neurokinin antagonists |
| 07/02/2003 | CN1113057C Quinoline derivatives |
| 07/02/2003 | CN1112931C Anti-stress drugs and functional foods having anti-stress effects |
| 07/01/2003 | US6586623 Thiol-based NAALADase inhibitors |
| 07/01/2003 | US6586596 Acetylcholine enhancers |
| 07/01/2003 | US6586582 Human GABA receptor proteins and polynucleotides encoding the same |
| 07/01/2003 | US6586474 Amidino compounds useful as nitric oxide synthase inhibitors |
| 07/01/2003 | US6586471 Halogenated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 07/01/2003 | US6586467 Tyrosine phosphatase inhibitors useful in the treatment or prevention of Type II Diabetes Mellitus |
| 07/01/2003 | US6586459 Antithrombotic agents |
| 07/01/2003 | US6586456 Corticotropin releasing factor (CRF) antagonists such as (4-(2-chloro-4-methoxy-5-methylphenyl)-5-methylthiazol-2-yl)(( (1-(3-fluoro-4-methylphenyl)-2-methoxyethyl))prop-2-ynylamine, prepared by alkylation with propagyl bromide |
| 07/01/2003 | US6586448 Cholesteryl ester transfer protein inhibitors used as antilipemic agents for prophylaxis of cardiovascular disorders |
| 07/01/2003 | US6586446 Chemotaxic cytokine agonists or antagonists such as N(3-acetylphlenyl)-N'-(-2-((-3-((4-fluorophenyl)methyl)-8 -azabicyclo(3.2.1)oct-8-yl)methyl)-(2R)-1-cyclohexyl)urea, used as antiinflammatory agents for asthma or allergies |
| 07/01/2003 | US6586445 Racemic mixtures of 1,2,3,4-tetra hydro-1-(4-methoxyphenyl)-3 -(4-phenyl-1H-imidazol-2-yl)-9H- pyrido(3,4-b)indole, which bind to somatostatin receptors and block sodium channel modulators; antidiabetic, antiinflammatory agents; diarrhea |
| 07/01/2003 | US6586442 Benzofurane derivatives, their preparation process, their use as medicaments and the pharmaceutical compositions containing them |
| 07/01/2003 | US6586441 Adenosine receptor ligands and their use in the treatment of disease |
| 07/01/2003 | US6586440 Uracil substituted at 5-position by C2-4 alkynyl used as inactivator of uracil reductase enzyme |
| 07/01/2003 | US6586439 Pharmaceutically active compounds |
| 07/01/2003 | US6586436 Serotonergic agents |
| 07/01/2003 | US6586434 Method for the preparation of tetrahydrobenzothiepines |
| 07/01/2003 | US6586432 Neurokinin-1 receptor antagonists |
| 07/01/2003 | US6586430 Administering azabicyclo compounds to treat human immunodeficiency virus infections and respiratory system disorders |
| 07/01/2003 | US6586429 For treatment of chronic inflammatory disease, chronic intestinalinflammation, arthritis, psoriasis, asthma, autoimmune disorders |
| 07/01/2003 | US6586428 Combined preparations comprising morpholine anthracyclines and anticancer agent |
| 07/01/2003 | US6586424 Anticancer agents; anticholesterol agents |
| 07/01/2003 | US6586423 Tyrosine kinase inhibitors |
| 07/01/2003 | US6586422 Pyrazine and triazine derivatives of 1,2,4,5-tetrahydro-Benzo or Thieno [d] azepine |
| 07/01/2003 | US6586421 For therapy of central nervous system, including diseases, disorders, and conditions related to, such as anxiety, depression, hypertension, migraine, obesity, compulsive disorders, schizophrenia, autism, neurodegenerative disorders |
| 07/01/2003 | US6586397 Polypeptides encoding tyrosine kinase containing immunoglobulin and endithelial growth factor homology domains; induce vascularization |
| 07/01/2003 | US6586391 Method of ameliorating erectile dysfunction |
| 07/01/2003 | US6586257 Detecting physico-chemical property of samples disposed on a platform using a detector having an adjustable parameter; storing information and adjusting parameters based on the information; use in high throughput drug screening |
| 07/01/2003 | US6586242 TAO protein kinases and methods of use therefor |
| 07/01/2003 | US6586206 Methods for making recombinant proteins using apoptosis inhibitors |
| 07/01/2003 | US6586179 Human Eag2 |
| 07/01/2003 | US6586020 Bradykinin antagonists comprising rosaceae plant extracts |
| 07/01/2003 | US6586015 Use of Phyllanthus for treating chronic inflammatory and fibrotic processes |
| 07/01/2003 | US6585997 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 07/01/2003 | US6585995 Administering to a subject to inhibit a vaso-occlusive event an agent that reduces platelet counts in the subject in an amount effective to reduce platelet count in the subject to at least a low normal level |
| 07/01/2003 | US6585971 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof |
| 07/01/2003 | US6585959 Excipient having different particle size distribution are added in alternate layers into a suitable mixing vessel; mixing together using a suitable mixer, wherein a portion of the excipient having the larger particle size is added first |
| 07/01/2003 | CA2256227C Method of treating psychiatric conditions |
| 07/01/2003 | CA2166243C Apoptosis-modulating composition containing a factor modifying intracellular methional and malondialdehyde rates |